K. Pavelka

EULAR/EFORT Recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee (2009)

Günther, Kp, Lukas, C, Braun, J, Combe, B, Conaghan, P G, ...

OBJECTIVES: The European League Against Rheumatism (EULAR) and the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) have recognized the importance of variation in...

EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT (2009)

Zhang, W, Doherty, M, Leeb, BF, Alekseeva, L, Arden, NK, Bijlsma, JW, ...

Objectives: To develop evidence-based recommendations for the diagnosis of hand osteoarthritis (OA). Methods: The multidisciplinary guideline development group, representing 15 European countries,...

Total Joint Replacement after Glucosamine Sulphate Treatment in Knee Osteoarthritis: Results of a Mean 8-Year Observation of Patients from Two Previous 3-Year, Randomised, Placebo-Controlled Trials (2008)

Bruyère, Olivier, Pavelka, K, Rovati, L C, Gatterova, J, Giacovelli, G, Olejarova, M, ...

OBJECTIVE: To assess the incidence of Total Joint Replacement (TJR) during the long-term follow-up of patients with knee osteoarthritis (OA) formerly receiving treatment with glucosamine sulphate or...

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists (2008)

Gossec, L., Dougados, M., Phillips, C., Hammoudeh, M., De Vlam, K., Pavelka, K., ...

Background: Ten ASAS/EULAR recommendations for the management of ankylosing spondylitis (AS) were published in 2006. Objectives: (a) To disseminate and (b) to evaluate conceptual agreement with, and...

Efficacy of Hylan GF20 (single dose) versus placebo in patients with pain due to knee osteoarthritis (2008)

Jerosch, J, Van Dijk, N, Verdonk, René, Price, A, Chevalier, X, Bailleul, F, ...

Randomised controlled trial showing single dose of Hylan G-F20 is safe and effective in patients with knee osteoarthritis pain (2008)

Bailleul, F, Jerosch, J, Van Dijk, NC, Verdonk, René, Price, A, Pavelka, K, ...

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2007)

Zhang, W., Doherty, M., Leeb, B.F., Alekseeva, L., Arden, N.K., Bijlsma, J.W., ...

OBJECTIVES: To develop evidence based recommendations for the management of hand osteoarthritis (OA). METHODS: The multidisciplinary guideline development group comprised 16 rheumatologists, one...

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT) (2007)

ZHANG, W, DOHERTY, M, LEEB, BF, ALEKSEEVA, L, ARDEN, NK, BIJLSMA, JW, ...

Dissemination and evaluation of the ASAS/EULAR recommendation for the management of ankylosing spondylitis: Results of a study among 1507 rheumatologists (2007)

Gossec, L., Kvien, T. K., Phillips, C., Hammoudeh, M., De Vlam, K., Pavelka, K., ...

Dissémination et évaluation des recommandations ASAS/EULAR pour la prise en charge de la Spondylarthrite Ankylosante (SA): résultats d’une étude chez 1,507 rhumatologues (2007)

Gossec, L, Kvien, TK, Phillips, C, Hammoudeh, M, De Vlam, K, Pavelka, K, ...

Commentary: osteoarthritis of the knee and glucosamine (2006)

Altman, RD, Abramson, S, Bruyère, Olivier, Clegg, D, Herrero-Beaumont, G, Maheu, E, ...

Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003 (2006)

Hanova, P., Pavelka, K., Dostal, C., Holcatova, I., Pikhart, H.

Objective: To estimate the annual incidence and prevalence of rheumatoid arthritis (RA), juvenile arthritis (JIA) and gout in a population based study in two regions of the Czech Republic with total...

Clinical significance of the long-term symptom-modifying effects of glucosamine sulfate: comment on the article by Brandt and Mazzuca (2006)

Bruyère, Olivier, Reginster, Jean-Yves, Giacovelli, G, Barbetta, B, Rovati, LC, Pavelka, K

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., GEUSENS, Piet, Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

ASAS/EULAR recommendations for the management of ankylosibg spondylitiis (2006)

Zochling, J, Burgos-Vargas, R, Collantes, E, Davis, JC, Dijkmans, B, ...

ASAS/EULAR recommendations for the management of ankylosing spondylitis. (2006)

Zochling, J, Burgos Vargas, R, Collantes, E, Davis, J C, Dijkmans, B, ...

OBJECTIVE: To develop evidence based recommendations for the management of ankylosing spondylitis (AS) as a combined effort of the 'ASsessment in AS' international working group and the European...

Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years (2006)

Strand, V., Balbir-Gurman, A., Pavelka, K., Emery, P., Li, N., Yin, M., ...

Objectives. To evaluate the long-term impact on physical function of a single course of rituximab in rheumatoid factor, seropositive patients with active rheumatoid arthritis (RA) despite ongoing...

Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years (2006)

Strand, V., Balbir-Gurman, A., Pavelka, K., Emery, P., Li, N., Yin, M., ...

Objectives. To evaluate the long-term impact on physical function of a single course of rituximab in rheumatoid factor, seropositive patients with active rheumatoid arthritis (RA) despite ongoing...

Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years (2006)

Strand, V., Balbir-Gurman, A., Pavelka, K., Emery, P., Li, N., Yin, M., ...

Objectives. To evaluate the long-term impact on physical function of a single course of rituximab in rheumatoid factor, seropositive patients with active rheumatoid arthritis (RA) despite ongoing...

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis (2005)

Altman, RD, Abadie, E, Avouac, B, Bouvenot, G, Branco, J, Bruyère, Olivier, ...

Objective: The Group for the Respect of Ethics and Excellence in Science (GREES) organized a working group to assess the value of time to joint surgery as a potential therapeutic failure outcome...

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005)

Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., ...

Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H., Rozman, B., Genovese, M., ...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H-D., Rozman, B., Genovese, M., ...

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005)

ZHANG, W, DOHERTY, M, ARDEN, N, BANNWARTH, B, BIJLSMA, J, GUNTHER, KP, ...

Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression (2003)

Pavelka, K, Senolt, L, Vilim, V, Spacek, P, Braun, M, Forejtova, S

No abstract available.

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) (2003)

Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P., ...

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach. Methods: The literature search and guidelines...

Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients (2003)

Codreanu, C, Combe, B, Fiocco, U, Gaubitz, M, Kvien, T, Pavelka, K, ...

Centrul Metodol Reumatol, Bucharest, Romania. Hop Lapeyronie, Serv ImmunoRhumatol, Montpellier, France. Polyclin Univ, Cattedra Reumatol, Azienda Clin Osped Padova, Padua, Italy. Polyclin Univ, Div...

Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients (2003)

Codreanu, C, Combe, B, Fiocco, U, Gaubitz, M, Kvien, T, Pavelka, K, ...

Centrul Metodol Reumatol, Bucharest, Romania. Hop Lapeyronie, Serv ImmunoRhumatol, Montpellier, France. Polyclin Univ, Cattedra Reumatol, Azienda Clin Osped Padova, Padua, Italy. Polyclin Univ, Div...

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) (2003)

JORDAN, KM, ARDEN, NK, DOHERTY, M, BANNWARTH, B, BIJLSMA, JWJ, DIEPPE, P, ...

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial (2003)

Pavelka, K., Recker, D. P., Verburg, K. M.

Objective. To compare the efficacy and upper gastrointestinal (GI) safety of valdecoxib 20 and 40 mg daily with those of diclofenac 75 mg slow release (SR) twice daily in treating rheumatoid...

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial (2003)

Pavelka, K., Recker, D. P., Verburg, K. M.

Objective. To compare the efficacy and upper gastrointestinal (GI) safety of valdecoxib 20 and 40 mg daily with those of diclofenac 75 mg slow release (SR) twice daily in treating rheumatoid...

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial (2003)

Pavelka, K., Recker, D. P., Verburg, K. M.

Objective. To compare the efficacy and upper gastrointestinal (GI) safety of valdecoxib 20 and 40 mg daily with those of diclofenac 75 mg slow release (SR) twice daily in treating rheumatoid...

Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis. (2002)

Combe, BG, Codreanu, C, Fiocco, U, Gaubitz, M, Kvien, TK, Pavelka, K, ...

H Lapeyron, Montpellier, France. C Metod Reumat, Bucharest, Romania. Clin Osp, Padua, Italy. Univ Munster, D-4400 Munster, Germany. Limburgs Univ Ctr, Diepenbeek, Belgium. Dia Syk, Oslo, Norway. Inst...

Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis. (2002)

Combe, BG, Codreanu, C, Fiocco, U, Gaubitz, M, Kvien, TK, Pavelka, K, ...

H Lapeyron, Montpellier, France. C Metod Reumat, Bucharest, Romania. Clin Osp, Padua, Italy. Univ Munster, D-4400 Munster, Germany. Limburgs Univ Ctr, Diepenbeek, Belgium. Dia Syk, Oslo, Norway. Inst...

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). (2000)

PENDLETON, A, ARDEN, N, DOUGADOS, M, DOHERTY, M, BANNWARTH, B, BIJLSMA, JWJ, ...

THE OCCURRENCE OF ADVERSE SIDE-EFFECTS DURING CONTROLLED CLINICAL TRIALS OF NONSTEROIDAL ANTIRHEUMATIC AGENTS (1980)

PAVELKA, K., VOJTISEK, O., KANKOVÁ, D.

The side-effects which occurred in the course of 13 controlled trials of new nonsteroidal anti-inflammatory drugs are reviewed. Of 1643 patients treated, 185 (11%) reported adverse effects...

DOUBLE-BLIND COMPARISON OF IBUPROFEN AND PHENYLBUTAZONE IN THE SHORT-TERM TREATMENT OF RHEUMATOID ARTHRITIS (1973)

PAVELKA, K., SUSTA, A., VOJTÍSEK, O., BREMOVÁ, A., KANKOVÁ, D., HÁNDLOVÁ, D., ...

A comprehensive double-blind and double-blind cross-over study of the antiphlogistic and analgesic properties of ibuprofen, 300 mg. four times daily, and phenylbutazone, 150 mg. four times daily, is...

Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens.

Pavelka, K, Sen, K P, Pelísková, Z, Vácha, J, Trnavský, K

A controlled, double blind, parallel group, long term study of hydroxychloroquine sulphate in the treatment of rheumatoid arthritis, comparing daily doses of 200 mg and 400 mg, is described. The...

Histological study of effects of colloidal 90 yttrium on knee joint tissues of rabbits.

Pavelka, K, Meier-Ruge, W, Müller, W, Fridrich, R

The administration of 0-2-0-4 mCi 90 yttrium (90Y) into a normal rabbit knee joint fails to induce medical synovectomy and results in the proliferation of the synovialis. The synovial mesothelium...

Effect of yttrium 90 on experimental allergic arthritis in rabbits.

Meier-Ruge, W, Müller, W, Pavelka, K

Seventeen rabbits were immunized with complete Freund's adjuvant and bovine serum albumin by the method of Dumonde and Glynn (1962), as modified by Cooke and Jasin (1972). Fifteen weeks after...

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Pendleton, A, Arden, N, Dougados, M, Doherty, M, Bannwarth, B, Bijlsma, J, ...

BACKGROUND—Osteoarthritis (OA) is the most common joint disease encountered throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in 1998 to determine the...

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Jordan, K, Arden, N, Doherty, M, Bannwarth, B, Bijlsma, J, Dieppe, P, ...

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach.

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Van Holten, J, Pavelka, K, Vencovsky, J, Stahl, H, Rozman, B, Genovese, M, ...

Objective: To assess the efficacy of interferon beta (IFNß) in combination with methotrexate in treatment of patients with rheumatoid arthritis.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Zhang, W, Doherty, M, Arden, N, Bannwarth, B, Bijlsma, J, Gunther, K, ...

Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).

Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein

Senolt, L, Braun, M, Olejarova, M, Forejtova, S, Gatterova, J, Pavelka, K

Background: Pentosidine, an advanced glycation end product, increasingly accumulates in articular cartilage with age, and contributes to the pathogenesis of osteoarthritis (OA). Increased...

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists

Gossec, L, Dougados, M, Phillips, C, Hammoudeh, M, De Vlam, K, Pavelka, K, ...

ASAS/EULAR recommendations for the management of ankylosing spondylitis

Zochling, J, Burgos‐Vargas, R, Collantes, E, Davis, J C, Dijkmans, B, ...

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, ...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double‐blind comparison

Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, ...